Please use this identifier to cite or link to this item:
Title: Clinical outcomes of transcatheter aortic valve implantation in nonagenarians.
Authors: Dick, Ronald
Duffy, Stephen
Stub, Dion
Walton, Anthony
Larobina, Marco
Marasco, Silvana
Other Authors: Leary, Olivia
Zamani, Jalal
Johnston, R.
Holland, S.
Keywords: Aortic Valve Replacement
Transcatheter Aortic Valve Implantation
Surgical Aortic Valve Replacement
Elderly Patients
Intermediate Risk Patients
Aortic Stenosis
High Risk Patients
Society of Thoracic Surgeons Score
Clinical Frailty Score
30-Day Mortality And Stroke
One Through To Six Year Survival
1 Through To 6 Year Survival
Clinical Outcomes
Victorian Heart Centre, Epworth HealthCare, Richmond, Victoria, Australia
Cardiac Sciences Clinical Institute, Epworth HealthCare, Victoria, Australia
Issue Date: Jun-2017
Citation: Epworth Research Institute Research Week 2017; Poster 21: pp 44-45
Conference Name: Epworth Research Institute Research Week 2017
Conference Location: Epworth Research Institute, Victoria, Australia
Abstract: BACKGROUND: Surgical Aortic Valve Replacement (SAVR) has been the gold standard for managmement of aortic stenosis until Transcatheter Aortic Valve Implementation (TAVI) emerged. TAVI is an alternative treatment option for intermediate and high risk patients. The aim of this research was to evaluate the clinical outcomes of the ≥90 years patient group compared with the <90 years patient group who have had TAVI at Epworth HealthCare and Alfred Hospital. METHODS: Data were prospectively collected from August 2008 to April 2017 on 559 patients. Data were divided into two groups, ≥90 and <90 year old. Data points included: Society of Thoracic Surgeons (STS) score, clinical frailty score (CFS), 30-day mortality and stroke, and one through to 6 year survival. RESULTS: Of 559 patients, 66 (33%) were nonagenarians. CFS of 3.9 (range 1-9). Average NYHA at discharge 1 (range 1-4). [See table on poster]. CONCLUSIONS: TAVI has become the preferred method of AVR in the elderly population. Our data suggest that TAVI can be undertaken safely in very elderly patients with good survival. Therefore, patients should not be excluded based on age alone. Careful work up in selected patients remains integral to optimal outcomes.
Type: Conference Poster
Affiliated Organisations: Alfred Hospital
Type of Clinical Study or Trial: Prospective Study
Appears in Collections:Cardiac Sciences
Research Week

Files in This Item:
There are no files associated with this item.

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.